We have collected information about Mark Sirgo Biodelivery Sciences for you. Follow the links to find out details on Mark Sirgo Biodelivery Sciences.
BioDelivery Sciences (BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA ® ) technology and other drug delivery technologies to develop and commercialize new applications of proven therapies ...
https://www.linkedin.com/in/drmarkasirgo
View Mark Sirgo’s profile on LinkedIn, the world's largest professional community. Mark has 4 jobs listed on their profile. See the complete profile on LinkedIn and discover Mark’s connections ...Title: CEO ArunA Bio
https://www.bizjournals.com/triangle/news/2017/08/23/bdsi-ceo-to-retire.html
Aug 23, 2017 · Dr. Mark Sirgo – who has served as president and CEO of Raleigh-based BioDelivery Sciences International (Nasdaq: BDSI) since 2005 – will retire at the end of this year.. He will stay on as ...
http://ir.bdsi.com/board-member/mark-sirgo
Mark A. Sirgo, Pharm.D., has been our Director since August 2005 and Vice Chairman since October 2016. He has served as Chief Executive Officer of ArunA Bio since January 2019. Formerly, he served as our President since January 2005 and Chief Executive Officer since August 2005.
https://www.marketwatch.com/investing/stock/bdsi/insiders?pid=16461578
Oct 02, 2019 · BioDelivery Sciences International Inc. individual insider activity by MarketWatch. ... Mark A. Sirgo currently is Chairman for RDD Pharma Ltd. and Chief Executive Officer & …
https://www1.salary.com/Mark-A-Sirgo-Pharm-D-Salary-Bonus-Stock-Options-for-BIODELIVERY-SCIENCES-INTL.html
As President, Director and Vice Chairman at BIODELIVERY SCIENCES INTERNATIONAL INC, Mark A. Sirgo Pharm.D. made $2,405,516 in total compensation. Of this total $590,000 was received as a salary, $264,000 was received as a bonus, $0 was received in stock options, $703,802 was awarded as stock and $847,714 came from other types of compensation. This information is according to proxy …
https://seekingalpha.com/article/4022756-biodelivery-sciences-bdsi-ceo-mark-sirgo-on-q3-2016-results-earnings-call-transcript
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Q3 2016 Earnings Conference Call November 9, 2016 8:00 AM ET Executives. Al Medwar - SVP Corporate and Business Development. Mark Sirgo - …Author: SA Transcripts
https://www.streetinsider.com/Corporate+News/BioDelivery+Sciences+%28BDSI%29+CEO+Dr.+Mark+A.+Sirgo+to+Retire%2C+Continue+as+Vice+Chairman/13229882.html
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will retire as BDSI's President and Chief Executive Officer, roles...
https://seekingalpha.com/article/4123129-biodeliverys-bdsi-ceo-mark-sirgo-on-q3-2017-results-earnings-call-transcript
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Q3 2017 Results Earnings Conference Call November 09, 2017, 04:30 PM ET Executives Al Medwar - …Author: SA Transcripts
https://www.prnewswire.com/news-releases/biodelivery-sciences-president-and-chief-executive-officer-dr-mark-a-sirgo-to-retire-at-year-end-while-continuing-as-vice-chairman-300508240.html
RALEIGH, N.C., Aug. 23, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that at the end of 2017, Dr. Mark A. Sirgo will retire as BDSI's President and ...
Searching for Mark Sirgo Biodelivery Sciences?
You can just click the links above. The data is collected for you.
